← Back to Search

Yoga for Scleroderma (GYYB Trial)

N/A

Waitlist Available

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Men and women fulfilling the 2013 ACR/EULAR Classification for Systemic Sclerosis

18 years of age or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 12

Awards & highlights

GYYB Trial Summary

This trial is testing whether yoga and breathing exercises can help manage symptoms in scleroderma patients. Two clinic visits and regular at-home practice over 3 months.

Who is the study for?

This trial is for men and women over 18 with any form of scleroderma, who are currently receiving treatment. Participants must be able to do gentle chair-based yoga movements and breathing exercises, have a working phone, and the ability to watch instructional videos online. It's not for those with psychiatric conditions that affect consent-giving, physical limitations preventing yoga practice, or anyone already doing regular yoga or in another yoga study.Check my eligibility

What is being tested?

The study tests if gentle yoga and yogic breathing can help manage symptoms in scleroderma patients. It involves initial training at MUSC followed by twice-daily home practice using video guidance for 12 weeks. Progress is tracked through diaries and weekly calls from the coordinator.See study design

What are the potential side effects?

Since this intervention involves only gentle movement and breathing exercises tailored for individuals with scleroderma, significant side effects are unlikely; however, participants may experience mild discomfort or muscle soreness typical of starting a new exercise regimen.

GYYB Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with systemic sclerosis according to the 2013 criteria.

Select...

I am 18 years old or older.

GYYB Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptance

Adherence

Depression

+4 more

GYYB Trial Design

1Treatment groups

Experimental Treatment

Group I: GYYBExperimental Treatment1 Intervention

This is a single-arm pre-post design.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor

932 Previous Clinical Trials

7,394,230 Total Patients Enrolled

3 Trials studying Scleroderma

450 Patients Enrolled for Scleroderma

Paul NietertUNKNOWN

Richard SilverUNKNOWN

Media Library

GYYB Clinical Trial Eligibility Overview. Trial Name: NCT04491396 — N/A

Scleroderma Clinical Trial 2023: GYYB Highlights & Side Effects. Trial Name: NCT04491396 — N/A

GYYB 2023 Treatment Timeline for Medical Study. Trial Name: NCT04491396 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still opportunity for patients to join this study?

"This research project, originally posted on August 1st 2020, is not presently enrolling study participants. However, clinicaltrials.gov lists 83 other medical studies that are actively seeking candidates at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Yoga Adjunct for Scleroderma

Sundaravadivel Balasubramanian 2020. "Yoga Adjunct for Scleroderma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04491396.

All > Scleroderma Research Foundation > Scleroderma